In March 2002, Theodore Friedmann, who directs the program in
human gene therapy at the University of California at San Diego and has advised the National Institutes of Health and congressional leaders on gene - related issues, organized a three - day workshop for the world agency.
«Those were very dark days when people worried the field was not going to survive,» says David T. Curiel, director of the division of
human gene therapy at the University of Alabama at Birmingham.
Theodore Friedmann, who directs the program in
human gene therapy at the University of California at San Diego, spearheaded the first of these workshops six years ago.
Not exact matches
A team of researchers
at the Stanford University School of Medicine has used a
gene - editing tool known as CRISPR to repair the
gene that causes sickle cell disease in
human stem cells, which they say is a key step toward developing a
gene therapy for the disorder.
The SMA model pig was created using a
gene therapy approach by knocking down the levels of pig SMN, followed by treatment with
human SMN
at early and late time points.
The author is director of the Program in
Human Gene Therapy, University of California
at San Diego School of Medicine, La Jolla, CA 92093 - 0634.
«Our
gene therapy protocol is not yet ready for clinical trials — we need to tweak it a bit more — but in the not - too - distant future we think it could be developed for therapeutic use in
humans,» says Jeffrey Holt, PhD, a scientist in the Department of Otolaryngology and F.M. Kirby Neurobiology Center
at Boston Children's and an associate professor of Otolaryngology
at Harvard Medical School.
In
humans, variants of the IL - 15R - alpha
gene have been found in world - class endurance competitors, suggesting a target for
gene therapies aimed
at boosting the ability to exercise longer.
The team
at UF's Powell Center for Rare Disease Research and
Therapy conducted the first in - human study of gene therapy to treat respiratory dysfunction in patients with infantile onset
Therapy conducted the first in -
human study of
gene therapy to treat respiratory dysfunction in patients with infantile onset
therapy to treat respiratory dysfunction in patients with infantile onset Pompe.
For the animal experiments, Savio Woo of the Center for
Gene Therapy at Baylor College of Medicine in Houston and his colleagues first isolated liver cells from transgenic mice that produce the
human protein a1 - antitrypsin in their livers, from where it is secreted into the blood.
For the past 3 months, faculty and staff members
at the University of Pennsylvania's Institute for
Human Gene Therapy have been trying to understand why a relatively fit 18 - year - old with an inherited enzyme deficiency died on 17 September, 4 days after doctors
at Penn injected a genetically altered virus into his liver.
PNP Therapeutics, Inc. — a company based on a
gene -
therapy technology developed by scientists
at Southern Research Institute and the University of Alabama
at Birmingham (UAB)-- has found an approach that has abolished otherwise unmanageable
human cancers in preclinical rodent studies.
On Aug. 3, the scientific article in Nature finally gave us some facts about the much - hyped experiments that involved editing the genomes of
human embryos
at the Center for Embryonic Cell and
Gene Therapy at Oregon Health and Science University.
At its conclusion, we will have a candidate
gene therapy for AMD; however, such
therapy will need to be tested for safety before being able to advance into
humans.
«It's unlikely we'll be doing
gene therapy like this for
humans, but
at least it gave us the rationale of why we want to enhance this pathway to prevent the complications of aging.»
Auburn University College of Veterinary Medicine, UMass Medical School to test
gene therapy treatment for Tay - Sachs and Sandhoff diseases Researchers
at Auburn University College of Veterinary Medicine and UMass Medical School are nearing
human clinical trials on a genetic
therapy for two rare neurological diseases that are fatal to children.